Aldeyra Therapeutics
ALDX
ALDX
108 hedge funds and large institutions have $353M invested in Aldeyra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+12
Holders Change %
+12.5%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
39
Reduced
25
Closed
8
Calls
$5.23M
Puts
$5.45M
Net Calls
-$214K
Net Calls Change
+$868K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$11.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$10.9M |
| 3 |
N
Natixis
Paris,
France
|
$6.7M |
| 4 |
Millennium Management
New York
|
$11.1M |
| 5 |
Goldman Sachs
New York
|
$2.85M |
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
$399K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$1.87M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
$3.81M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$766K |
| 5 |
Two Sigma Investments
New York
|
$2.19M |
